vs
Side-by-side financial comparison of Capstone Holding Corp. (CAPS) and ENANTA PHARMACEUTICALS INC (ENTA). Click either name above to swap in a different company.
ENANTA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($18.6M vs $14.0M, roughly 1.3× Capstone Holding Corp.). Capstone Holding Corp. runs the higher net margin — -14.4% vs -64.1%, a 49.7% gap on every dollar of revenue.
Capstone Green Energy Corporation, formerly Capstone Turbine Corporation, was incorporated in 1988 as a California based gas turbine manufacturer that specializes in microturbine power along with heating and cooling cogeneration systems. Key to the Capstone design is its use of air bearings, which provides maintenance and fluid-free operation for the lifetime of the turbine and reduces the system to a single moving part. This also eliminates the need for any cooling or other secondary systems...
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
CAPS vs ENTA — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $14.0M | $18.6M |
| Net Profit | $-2.0M | $-11.9M |
| Gross Margin | 23.3% | — |
| Operating Margin | -5.5% | -60.5% |
| Net Margin | -14.4% | -64.1% |
| Revenue YoY | — | 9.8% |
| Net Profit YoY | — | 46.4% |
| EPS (diluted) | $-0.35 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.6M | ||
| Q3 25 | $14.0M | $15.1M | ||
| Q2 25 | $13.2M | $18.3M | ||
| Q1 25 | $8.2M | $14.9M | ||
| Q4 24 | — | $17.0M | ||
| Q3 24 | — | $14.6M | ||
| Q2 24 | — | $18.0M | ||
| Q1 24 | — | $17.1M |
| Q4 25 | — | $-11.9M | ||
| Q3 25 | $-2.0M | $-18.7M | ||
| Q2 25 | $-700.0K | $-18.3M | ||
| Q1 25 | $-1.7M | $-22.6M | ||
| Q4 24 | — | $-22.3M | ||
| Q3 24 | — | $-28.8M | ||
| Q2 24 | — | $-22.7M | ||
| Q1 24 | — | $-31.2M |
| Q4 25 | — | — | ||
| Q3 25 | 23.3% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 16.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -60.5% | ||
| Q3 25 | -5.5% | -121.6% | ||
| Q2 25 | -2.0% | -103.2% | ||
| Q1 25 | -17.5% | -164.3% | ||
| Q4 24 | — | -138.8% | ||
| Q3 24 | — | -204.4% | ||
| Q2 24 | — | -134.6% | ||
| Q1 24 | — | -192.1% |
| Q4 25 | — | -64.1% | ||
| Q3 25 | -14.4% | -123.6% | ||
| Q2 25 | -5.3% | -99.7% | ||
| Q1 25 | -21.2% | -151.7% | ||
| Q4 24 | — | -131.4% | ||
| Q3 24 | — | -197.3% | ||
| Q2 24 | — | -126.1% | ||
| Q1 24 | — | -182.7% |
| Q4 25 | — | $-0.42 | ||
| Q3 25 | $-0.35 | $-0.88 | ||
| Q2 25 | $-0.13 | $-0.85 | ||
| Q1 25 | $-0.47 | $-1.06 | ||
| Q4 24 | — | $-1.05 | ||
| Q3 24 | — | $-1.36 | ||
| Q2 24 | — | $-1.07 | ||
| Q1 24 | — | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $730.0K | $37.4M |
| Total DebtLower is stronger | $11.7M | — |
| Stockholders' EquityBook value | $27.2M | $126.6M |
| Total Assets | $58.5M | $329.5M |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $37.4M | ||
| Q3 25 | $730.0K | $32.3M | ||
| Q2 25 | $773.0K | $44.8M | ||
| Q1 25 | $1.7M | $60.2M | ||
| Q4 24 | — | $84.3M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $35.8M | ||
| Q1 24 | — | $63.5M |
| Q4 25 | — | — | ||
| Q3 25 | $11.7M | — | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $8.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $126.6M | ||
| Q3 25 | $27.2M | $64.7M | ||
| Q2 25 | $26.3M | $79.3M | ||
| Q1 25 | $27.0M | $93.5M | ||
| Q4 24 | — | $111.8M | ||
| Q3 24 | — | $128.8M | ||
| Q2 24 | — | $148.9M | ||
| Q1 24 | — | $166.1M |
| Q4 25 | — | $329.5M | ||
| Q3 25 | $58.5M | $280.7M | ||
| Q2 25 | $51.9M | $301.0M | ||
| Q1 25 | $52.2M | $323.0M | ||
| Q4 24 | — | $348.6M | ||
| Q3 24 | — | $376.7M | ||
| Q2 24 | — | $398.8M | ||
| Q1 24 | — | $413.6M |
| Q4 25 | — | — | ||
| Q3 25 | 0.43× | — | ||
| Q2 25 | 0.37× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $0 | $-11.7M |
| Free Cash FlowOCF − Capex | — | $-11.8M |
| FCF MarginFCF / Revenue | — | -63.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-11.7M | ||
| Q3 25 | $0 | $-6.5M | ||
| Q2 25 | $-1.7M | $17.5M | ||
| Q1 25 | $-2.3M | $-13.5M | ||
| Q4 24 | — | $-16.8M | ||
| Q3 24 | — | $-10.4M | ||
| Q2 24 | — | $-14.8M | ||
| Q1 24 | — | $-28.6M |
| Q4 25 | — | $-11.8M | ||
| Q3 25 | — | $-7.9M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | — | $-16.0M | ||
| Q4 24 | — | $-25.5M | ||
| Q3 24 | — | $-19.4M | ||
| Q2 24 | — | $-21.3M | ||
| Q1 24 | — | $-30.3M |
| Q4 25 | — | -63.6% | ||
| Q3 25 | — | -52.5% | ||
| Q2 25 | — | 94.7% | ||
| Q1 25 | — | -107.4% | ||
| Q4 24 | — | -150.6% | ||
| Q3 24 | — | -132.5% | ||
| Q2 24 | — | -118.6% | ||
| Q1 24 | — | -177.5% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | 0.0% | 9.6% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 51.6% | ||
| Q3 24 | — | 61.3% | ||
| Q2 24 | — | 36.4% | ||
| Q1 24 | — | 9.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAPS
| Total Stone | $12.7M | 91% |
| Other | $1.3M | 9% |
ENTA
Segment breakdown not available.
